A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial Grant

Duke Scholars

Principal Investigator Richard Francis Riedel Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Ayala Pharmaceuticals, Inc

Start Date

November 12, 2021

End Date

March 26, 2024

Administered By

Duke Cancer Institute

Awarded By

Ayala Pharmaceuticals, Inc

Start Date

November 12, 2021

End Date

March 26, 2024